Please try another search
Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia.
Name | Age | Since | Title |
---|---|---|---|
Nickolaos Samaras | - | 2008 | Independent Non-Executive Chairman |
John R. Melki | - | 2011 | MD, CEO & Executive Director |
Anthony John Radford | 65 | 2015 | Non-Independent Non-Executive Director |
Neil Gunn | - | 2021 | Non-Executive Director |
Caroline Waldron | - | 2022 | Non-Executive Director |
Christopher M. Abbott | - | - | Founder & Chairman Emeritus |
Michael Anton Aicher | 63 | 2014 | Executive Director of US Operations & Executive Director |
Stéphane Chatonsky | - | 2023 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review